Project description
and objectives:
|
The proposed project will assist in the expansion of private health care
management in Hungary’s hospital and hospital pharmacy sector by supporting a
leading hospital management company in its development.
|
Transition impact:
|
EBRD’s investment in the sector will have a significant transition impact
through:
(i) Demonstration effect from participating in the restructuring of the public
hospital sector and from increased service quality
-
Hospinvest will restructure and rationalise the network of hospitals under
their management, by completing site reorganisation, reducing excessive beds,
integrating in-patient and out-patient centres. Refurbishment and
modernisation of resulting units are expected.
-
Rationalisation and improved efficiency of hospitals. Hospinvest has built up
a professional team that is capable of managing a network of health care
institutions. Cost savings are expected from economies of scale, unified
systems and advanced data processing and analysis capabilities. Further cost
savings are also expected from better organisation of procurement of medical
supplies.
(ii) Skills transfer and associated demonstration effects are expected from
the introduction of the most advanced treatment and operational methods as a
result of the Hospinvest medical board developing and implementing case
management protocols and a peer review system. Also, there is likely to be an
increase in the level of professional knowledge required by hospitals from
service providers (e.g. accounting firms, software developers, management
consultants).
(iii) Demonstration effect of the promotion of transparent procedures and the
concept of “value for money” in contracting private service providers.
|
The client:
|
Hospinvest is a private hospital and hospital pharmacy management company
owned by local entrepreneurs. It is currently managing three public hospitals
and adjacent out-patient centres as well as seven hospital pharmacies across
Hungary.
|
EBRD finance:
|
The Bank will invest EUR 4 million in equity along the current shareholders of
the Company.
|
Total project cost:
|
EUR 8 million.
|
Environmental impact:
|
Screened C/1 requiring a corporate audit of Hospinvest facilities. Based on
environmental due diligence, this project will have limited potential adverse
environmental and social impact. Also any impact will be few in number,
site-specific, reversible, and easily addressed through agreed mitigation
measures. Hospinvest complies with the labour laws of the country and have a
corporate occupational health and safety (OHS) policy as well as detailed
procedures in place. The hospitals have strict protocols for the management of
internationally recognised disinfection and sterilization programmes including
new steam sterilization equipments and new gamma sterilization equipment. All
waste arising including hazardous waste, infectious waste (waste with a
potential content of pathogens or biological agents) and pathological waste
(human tissues or fluids) is treated in accordance with best international
practice and EU standards.
The Company will be required to comply with national and EU environmental,
health, safety and labour standards and requirements and to report regularly
to the Bank on these issues.
|
Technical
cooperation:
|
None.
For consultant opportunities for projects financed by technical cooperation
funds, visit procurement
of consultants.
|
Company contact:
|
Mr. Jeno Gaszpor, CEO
Email: Gaszporj@hospinvest.hu
|
EBRD contact:
|
Pal Rajnai, Operation Leader: rajnaip@ebrd.com
|
Business opportunities:
|
For business opportunities or procurement, contact the client company.
|
General enquiries:
|
EBRD project enquiries not related to procurement:
Tel: +44 20 7338 7168; Fax: +44 20 7338 7380
Email: projectenquiries@ebrd.com
|
